European Fund for Strategic Investments (EFSI)
The European Fund for Strategic Investments (EFSI) is an initiative launched jointly by the EIB Group and the European Commission to help overcome the current investment gap in the EU by mobilising private financing for strategic investments.
EFSI dashboard (updated 23 September 2016)
The figures on this page are not part of formal EIB Group reporting on EFSI. Therefore, they are provisional and unaudited. The figures are subject to change. Approvals of EIB projects by the EIB Board of Directors are a requirement for financing negotiations with project promoters which, if successful, lead to signatures.
Extension of EFSI
The European Fund for Strategic Investments is delivering concrete results, encouraging a sustainable increase in the low investment levels in Europe after the financial crisis.
To further boost investment, to avoid disruptions in financing and to assure project promoters that they can still prepare projects even after the initial investment period, the European Commission proposed to double the duration and size of EFSI.
Energies POSIT’IF renovates thousands of condominiums in the Paris region, and they just received a helping hand in the form of a EUR 100 million loan from the European Investment Bank as part of the Investment Plan for Europe. It will now be able to use the EIB loan to offer financing to the owners. Find out how on our video.
The European Investment Bank, the EU bank, loaned EUR 15 million to Creta Farms in June. The loan is backed by EFSI’s EU budget guarantee and EIB resources, which aim to trigger EUR 315 billion of investment across Europe by 2018. It was needed because Greek banks are reluctant to lend in the wake of years of economic upheaval. The loan will help finance expensive advances in Creta Farms’ oliving technology, as well as its international expansion.
No download formats are defined.
Spanish researcher Angelita Rebollo has developed a technique for blocking specific functions of proteins that turn a healthy cell into a cancer cell. The treatment could help people with a range of illnesses, including ovarian and breast cancers. Her research led her to found a company, PEP-Therapy which was supported with EUR 1m from the Quadrivium 1 Fund. The fund recently received a EUR 20m injection from the EIF under EFSI.